PHARMACIE SCHOUTETEN
ActivePHARMACIE SCHOUTETEN has been active since 2004 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €637k and a net result of €64k. Equity is growing by ~9.8% per year across the filed fiscal years. Its solvency ranks better than 68% of 10359 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.5% (low).
Checked score
Score 2025
74
/ 100
Healthy
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability76▼-2
Solvency80▼-3
Growth78=
Track record100
Bankruptcy probability, 12 months
0.5%
Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €45k at 30 days acceptable
Liquidity ample (current ratio 2.89 against 4.23 in 2024; short-term debt: 22.9% and cash: 12.9% of total assets), and 44.7% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Seven signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Sector 47
higher
← fewer bankruptcies
more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
55.3%
Return on assets
5.5%
Age of the figures
9 mo
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 31-08-2026, 31 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filingsDeviation from the deadline
2025
31 d late
2024
29 d late
2023
1 d early
2022
4 d early
2021
29 d late
2020
28 d late
2019
25 d late
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
23-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, abbreviated schema
Turnover
Not included in this filing
EBIT margin
Not included in this filing
Net result
€64k▼ 15.4%
2024 · €75k
2018: €28k
2019: €-5k
2020: €25k
2021: €66k
2022: €42k
2023: €44k
2024: €75k
2018 → 2025
Working capital
€499k▲ 8.7%
2024 · €459k
2018: €351k
2019: €335k
2020: €156k
2021: €393k
2022: €407k
2023: €408k
2024: €459k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€412k-€454k▲ 10.3%€498k▲ 9.6%€573k▲ 15.2%€637k▲ 11.1%
Operating result€94k-€64k▼ 31.3%€65k▲ 0.5%€103k▲ 58.3%€95k▼ 7.5%
Net result€66k-€42k▼ 35.9%€44k▲ 3.0%€75k▲ 72.9%€64k▼ 15.4%
Result per fiscal year
Operating resultNet result
The operating result falls in 2025; 2025 is 7% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €1.15M
Fixed assets
€390k▼ 0.7%
Current assets
€763k▲ 27.0%
Equity and liabilities €1.15M
Equity
€637k▲ 11.1%
Debt
€515k▲ 22.7%
The debt ratio rises from 42.3% to 44.7%. Equity and debt are higher.
Key figures and ratios
EBITDA
€113k▼
2024 · €119k
Cash flow
€82k▼
2024 · €92k
Solvency
55.3%▼
2024 · 57.7%
Current ratio
2.89▼
2024 · 4.23
Quick ratio
2.37▼
2024 · 3.38
Debt / equity
0.81▲
2024 · 0.73
ROE
10.0%▼
2024 · 13.2%
ROA
5.5%▼
2024 · 7.6%
Interest coverage
11.56▼
2024 · 14.22
Debt
€515k▲
2024 · €420k
Debt ≤ 1 year
€264k▲
2024 · €142k
Debt > 1 year
€251k▼
2024 · €276k
Income taxes
€23k▼
2024 · €27k
Staff costs
€56k▲
2024 · €46k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€993k€1.15M▲
Fixed assets21/28€392k€390k▼
Tangible fixed assets22/27€392k€390k▼
Land and buildings22€382k€376k▼
Plant, machinery and equipment23€7k€10k▲
Furniture and vehicles24€3k€3k▼
Current assets29/58€601k€763k▲
Stocks and contracts in progress3€121k€138k▲
Stocks30/36€121k€138k▲
Amounts receivable within one year40/41€80k€169k▲
Trade receivables40€70k€146k▲
Other amounts receivable41€10k€23k▲
Current investments50/53€258k€305k▲
Cash at bank and in hand54/58€142k€148k▲
Deferred charges and accrued income490/1€440€2k▲
Equity and liabilities
Total equity and liabilities10/49€993k€1.15M▲
Equity10/15€573k€637k▲
Contributions10/11€19k€19k=
Reserves13€555k€619k▲
Distributable reserves133€555k€619k▲
Amounts payable17/49€420k€515k▲
Amounts payable after more than one year17€276k€251k▼
Financial debts170/4€276k€251k▼
Amounts payable within one year42/48€142k€264k▲
Current portion of amounts payable after more than one year42€36k€25k▼
Trade debts44€98k€131k▲
Suppliers440/4€98k€131k▲
Advances received on contracts in progress46-€73k
Taxes, remuneration and social security45€6k€32k▲
Taxes450/3-€23k
Remuneration and social security454/9€6k€9k▲
Other amounts payable47/48€3k€3k▼
Accrued charges and deferred income492/3€2k€0▼
Income statement
Code20242025
Remuneration, social security and pensions62€46k€56k▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€16k€18k▲
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4€891€0▼
Other operating charges640/8€3k€3k▼
Gross operating margin9900€168k€172k▲
Operating profit (loss)9901€103k€95k▼
Financial income75/76B€8k€2k▼
Recurring financial income75€8k€2k▼
Financial charges65/66B€8k€10k▲
Recurring financial charges65€8k€10k▲
Profit (loss) for the period before taxes9903€102k€87k▼
Income taxes67/77€27k€23k▼
Profit (loss) for the period9904€75k€64k▼
Profit (loss) for the period to be appropriated9905€75k€64k▼
Appropriation of the result
Profit (loss) to be appropriated9906€75k€64k▼
Transfer to equity691/2€75k€64k▼
To other reserves6921€75k€64k▼
Social balance
Average headcount (FTE)9087-0.8
The notes to these accounts (18 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
31-08
NBB filing
Annual accounts filed
fiscal year 2025 · abbreviated schema · 31 days late
2025
29-08
NBB filing
Annual accounts filed
fiscal year 2024 · full schema · 29 days late
2024
31-12
Financial
Highest result since 2018net €75k ▲72.9%
Operating result €103k, net result €75k, both a record.
31-12
Financial
Equity above €500kEq €573k ▲15.2%
5 profitable years in a row build equity to €573k.
30-07
NBB filing
Annual accounts filed
fiscal year 2023 · full schema
2023
27-07
NBB filing
Annual accounts filed
fiscal year 2022 · full schema
2022
29-08
NBB filing
Annual accounts filed
fiscal year 2021 · full schema · 29 days late
2021
31-12
Financial
Liquidity triplescurrent ratio 5.03
Current ratio from 1.51 to 5.03; short-term debt falls from €308k to €98k.
28-08
NBB filing
Annual accounts filed
fiscal year 2020 · full schema · 28 days late
2020
31-12
Financial
Back to profitnet €25k
Net result €25k after one loss-making year.
25-08
NBB filing
Annual accounts filed
fiscal year 2019 · full schema · 25 days late
2019
31-12
Financial
Weakest financial yearnet €-5k ▼117%
Net result drops to €-5k, the lowest in the series; recovery starts the following year.
23-08
NBB filing
Annual accounts filed
fiscal year 2018 · full schema · 23 days late
2018
30-08
NBB filing
Annual accounts filed
fiscal year 2017 · full schema · 30 days late
2017
30-08
NBB filing
Annual accounts filed
fiscal year 2016 · full schema · 30 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
3 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Comines-Warneton · 1 establishment unit since 2004
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Armentieresstraat(PL) 1537782 Comines-WarnetonGround area
4,066 m²
Building footprint
196 m²
Parcel 54008D0273/00H000, Wallonia. Linked by address, not a title deed.
1 establishment unit
Pharmacie Goddeeris
since 20042.135.352.456
1 parcel
Wallonia
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 54008D0273/00H000 | Wallonia | 4,066 m² | 1 · 196 m² | - |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Recognitions · licences · registrations
Food safety, FASFC
1 siteComines-Warneton/Komen-Waasten2.135.352.456
Similar companies · same sector, comparable size
RAMSELPHARMA
BE 0444.246.736
Herselt · Eq €637k
APOTHEEK COGGHE
BE 0429.160.167
Sint-Katelijne-Waver · Eq €637k
HOLSBEEK BRECHT - SINT -LENAERTS
BE 0415.789.807
Brecht · Eq €638k
SAINT-MARTIN
BE 0463.254.380
Frasnes-lez-Anvaing · Eq €637k
APOTHEEK VIAENE
BE 0865.063.717
Deerlijk · Eq €638k
Of 5,222 companies in sector 47730 we hold annual accounts for 3,861. 3,265 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded05-02-2004
Fiscal year end31-12
Activities, NACEBEL
47730Retail sale of pharmaceutical products
52310
Sources
Crossroads Bank for EnterprisesNational Bank · 22 filingsAddress and cadastre registers
Data from official sources, last processed on 23-09-2026. Scores and ratios are computed by Checked and are not a credit decision.